Table 1 Distribution of CD3 scores in the tumor front, center, and the intraepithelial compartment, in all cases and in subgroups based on MSI screening status and CIMP status
Tumor compartment | Front | Pa | Center | Pa | Intraepithelially | Pa | |||
---|---|---|---|---|---|---|---|---|---|
CD3 score | CD3 score | CD3 score | |||||||
1–2 | 3–4 | 1–2 | 3–4 | 1–2 | 3–4 | ||||
All cases | 344 | 117 | 386 | 97 | 377 | 101 | |||
MSI screening status, n (%) | 0.004 | 0.075 | 0.00027 | ||||||
MSI | 42 (12) | 27 (24) | 52 (14) | 20 (21) | 45 (12) | 27 (27) | |||
MSS | 294 (88) | 86 (76) | 323 (86) | 74 (79) | 320 (88) | 72 (73) | |||
CIMP status, n (%) | 0.292 | 0.036 | 0.001 | ||||||
CIMP-negativeb | 173 (50) | 55 (47) | 190 (49) | 53 (55) | 194 (51) | 46 (46) | |||
CIMP-lowb | 134 (39) | 43 (37) | 155 (40) | 27 (28) | 148 (39) | 32 (32) | |||
CIMP-highb | 37 (11) | 19 (16) | 41 (11) | 17 (18) | 35 (9) | 23 (23) |